Increasing demand for calcium supplements due to rising instances of bone-related health issues among the aging population is driving the growth of the calcium gluconate market. Furthermore, the expanding pharmaceutical industry and growing awareness about the importance of calcium intake for overall health and wellness are also fueling market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Grade, Form, Function, Application |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Pfizer, Novartis, Amphastar, Akorn, West-Ward Pharmaceuticals, Fresenius Kabi USA, Merck, Mylan Institutional LLC, Grifols USA LLC, Baxter International |
High costs associated with calcium gluconate production and limited availability of raw materials are major restraints hindering market growth. Additionally, regulatory challenges in terms of product approval and safety standards are impeding the market expansion.